Assetmark, Inc Astrazeneca PLC Transaction History

Assetmark, Inc

$45.6 Billion
Q3 2025

A detailed history of Assetmark, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Assetmark, Inc holds 310,383 shares of AZN stock, worth $27.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

310,383

Previous 291,363 6.53%

Holding current value

$27.7 Million

Previous $20.4 Million 16.95%

% of portfolio

0.05%

Previous 0.05%

40 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$68.72 - $82.11 $1.31 Million - $1.56 Million	19,020 Added 6.53%	310,383 $23.8 Million
Q2 2025 Aug 04, 2025	BUY	$64.87 - $75.0 $1.76 Million - $2.03 Million	27,100 Added 10.25%	291,363 $20.4 Million
Q1 2025 May 06, 2025	BUY	$65.37 - $77.96 $1.7 Million - $2.03 Million	26,014 Added 10.92%	264,263 $19.4 Million
Q4 2024 Feb 06, 2025	BUY	$63.2 - $79.58 $696,464 - $876,971	11,020 Added 4.85%	238,249 $15.6 Million
Q3 2024 Nov 01, 2024	BUY	$76.67 - $87.62 $974,092 - $1.11 Million	12,705 Added 5.92%	227,229 $17.7 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $1.28 Million - $1.55 Million	19,193 Added 9.83%	214,524 $16.7 Million
Q1 2024 May 06, 2024	BUY	$61.03 - $69.57 $2.47 Million - $2.81 Million	40,425 Added 26.1%	195,331 $13.2 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $968,083 - $1.08 Million	15,642 Added 11.23%	154,906 $10.4 Million
Q3 2023 Oct 27, 2023	BUY	$64.85 - $71.7 $632,222 - $699,003	9,749 Added 7.53%	139,264 $9.43 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $346,683 - $375,941	4,959 Added 3.98%	129,515 $9.27 Million
Q1 2023 May 05, 2023	BUY	$63.15 - $71.6 $571,444 - $647,908	9,049 Added 7.83%	124,556 $8.65 Million
Q4 2022 Feb 10, 2023	BUY	$54.21 - $70.44 $1.11 Million - $1.44 Million	20,479 Added 21.55%	115,507 $7.83 Million
Q3 2022 Nov 01, 2022	BUY	$53.02 - $135.75 $1.12 Million - $2.86 Million	21,038 Added 28.43%	95,028 $5.21 Million
Q2 2022 Aug 03, 2022	BUY	$59.26 - $71.14 $1.76 Million - $2.12 Million	29,736 Added 67.19%	73,990 $4.89 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $1.31 Million - $1.58 Million	23,483 Added 113.06%	44,254 $2.94 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $428,810 - $506,682	7,938 Added 61.86%	20,771 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $464,703 - $508,447	8,364 Added 187.16%	12,833 $771,000
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $37,622 - $46,759	777 Added 21.05%	4,469 $268,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $9,856 - $11,377	-209 Reduced 5.36%	3,692 $184,000
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $3,833 - $4,583	-79 Reduced 1.98%	3,901 $195,000
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $656,528 - $755,868	-12,371 Reduced 75.66%	3,980 $218,000
Q2 2020 Aug 11, 2020	SELL	$43.1 - $55.31 $10.7 Million - $13.7 Million	-248,110 Reduced 93.82%	16,351 $865,000
Q1 2020 May 12, 2020	SELL	$37.79 - $51.33 $331,380 - $450,112	-8,769 Reduced 3.21%	264,461 $11.8 Million
Q4 2019 Feb 11, 2020	BUY	$42.46 - $50.46 $3.93 Million - $4.67 Million	92,641 Added 51.3%	273,230 $13.6 Million
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $79,798 - $90,439	1,989 Added 1.11%	180,589 $8.05 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $6.5 Million - $7.26 Million	174,229 Added 3986.02%	178,600 $7.37 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $15,757 - $19,100	-444 Reduced 9.22%	4,371 $177,000
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $49,023 - $55,181	-1,330 Reduced 21.64%	4,815 $183,000
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $10,428 - $11,916	-300 Reduced 4.65%	6,145 $243,000
Q2 2018 Aug 01, 2018	SELL	$34.55 - $37.05 $2,936 - $3,149	-85 Reduced 1.3%	6,445 $226,000
Q1 2018 May 16, 2018	SELL	$32.97 - $36.63 $16,682 - $18,534	-506 Reduced 7.19%	6,530 $228,000
Q4 2017 Feb 13, 2018	SELL	$32.09 - $34.78 $3.12 Million - $3.38 Million	-97,191 Reduced 93.25%	7,036 $244,000
Q3 2017 Nov 08, 2017	SELL	$28.96 - $34.0 $3.03 Million - $3.55 Million	-104,487 Reduced 50.06%	104,227 $3.53 Million
Q2 2017 Aug 15, 2017	BUY	N/A	17,306 Added 9.04%	208,714 $7.12 Million
Q1 2017 Sep 15, 2017	BUY	N/A	82,797 Added 76.23%	191,408 $5.96 Million
Q4 2016 Sep 15, 2017	BUY	N/A	10,296 Added 10.47%	108,611 $2.97 Million
Q3 2016 Sep 15, 2017	SELL	N/A	-10,659 Reduced 9.78%	98,315 $3.23 Million
Q2 2016 Sep 15, 2017	BUY	N/A	7,894 Added 7.81%	108,974 $3.29 Million
Q1 2016 Sep 15, 2017	BUY	N/A	16,061 Added 18.89%	101,080 $2.85 Million
Q4 2015 Sep 15, 2017	BUY	N/A	85,019	85,019 $2.89 Million

Others Institutions Holding AZN

# of Institutions

1,501

Shares Held

500M

Call Options Held

5.64M

Put Options Held

3.2M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account